Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.
Khattab S, Wan G, Xu S, Moseley C, Tran M, Beagles E, Lin C, Leung B, Azin M, Hao N, Reynolds KL, Demehri S, LeBoeuf NR, Semenov YR. Khattab S, et al. Among authors: moseley c. medRxiv [Preprint]. 2025 Jan 8:2025.01.07.25320156. doi: 10.1101/2025.01.07.25320156. medRxiv. 2025. PMID: 39830283 Free PMC article. Preprint.
Distinct plasma lipids predict axonal injury and multiple sclerosis activity.
Schoeps VA, Bhargava P, Virupakshaiah A, Ladakis DC, Moseley C, Chong J, Aaen G, Graves JS, Benson L, Gorman MP, Rensel M, Abrams A, Mar S, Lotze TE, Chitnis T, Waldman A, Krupp L, Rodriguez M, Tillema JM, Rose J, Schreiner T, Qureshi F, Peterson S, Barcellos LF, Casper TC, Newman J, Borkowski K, Waubant E; US Network of Pediatric MS Centers. Schoeps VA, et al. Among authors: moseley c. J Neurol Neurosurg Psychiatry. 2025 Jan 16;96(2):150-157. doi: 10.1136/jnnp-2024-333652. J Neurol Neurosurg Psychiatry. 2025. PMID: 39266284
Should We Measure CSF Complement Levels in Patients With MOGAD?
Moseley CE, Zamvil SS. Moseley CE, et al. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200302. doi: 10.1212/NXI.0000000000200302. Epub 2024 Aug 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39133884 Free PMC article. No abstract available.
MOG CNS Autoimmunity and MOGAD.
Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS. Moseley CE, et al. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200275. doi: 10.1212/NXI.0000000000200275. Epub 2024 Jul 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38996203 Free PMC article. Review.
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease.
Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant E. Virupakshaiah A, et al. Among authors: moseley ce. J Neurol Neurosurg Psychiatry. 2024 Dec 16;96(1):68-75. doi: 10.1136/jnnp-2024-333464. J Neurol Neurosurg Psychiatry. 2024. PMID: 38964848
Life-Threatening MOG Antibody-Associated Hemorrhagic ADEM With Elevated CSF IL-6.
Virupakshaiah A, Moseley CE, Elicegui S, Gerwitz LM, Spencer CM, George E, Shah M, Cree BAC, Waubant E, Zamvil SS. Virupakshaiah A, et al. Among authors: moseley ce. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200243. doi: 10.1212/NXI.0000000000200243. Epub 2024 Apr 17. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38630950 Free PMC article.
Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.
Rashdan H, Zhang S, Wan G, Nguyen N, Roster K, Rajeh A, Tang K, Chen W, Moseley C, Chen S, LeBoeuf N, Semenov YR. Rashdan H, et al. Among authors: moseley c. J Am Acad Dermatol. 2024 May;90(5):1080-1083. doi: 10.1016/j.jaad.2024.01.038. Epub 2024 Jan 28. J Am Acad Dermatol. 2024. PMID: 38290617 No abstract available.
Targeting PGLYRP1 in cancer and autoimmunity.
Moseley CE, Zamvil SS. Moseley CE, et al. Nat Immunol. 2023 Nov;24(11):1785-1786. doi: 10.1038/s41590-023-01649-0. Nat Immunol. 2023. PMID: 37828380 No abstract available.
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma.
Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Wan G, et al. Among authors: moseley cb. J Am Acad Dermatol. 2024 Feb;90(2):288-298. doi: 10.1016/j.jaad.2023.08.105. Epub 2023 Oct 4. J Am Acad Dermatol. 2024. PMID: 37797836
127 results